Clinical Trials Browser

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Hematologic Neoplasms, Triple Negative Breast Neoplasms

Clinical Trials

Bintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain Metastases

TOP 1501

Priming Immunotherapy in Advanced Disease With Radiation

SPRINT

Pembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain Metastases

iSMART

Understanding the Post-Surgical Non-Small Cell Lung Cancer Patient's Symptom Experience

Nivolumab Plus Cisplatin/Pemetrexed or Cisplatin/Gemcitabine as Induction in Resectable Non-Small Cell Lung Cancer

MK-3475 and Gemcitabine in Non-Small Cell Lung Cancer (NSCLC)

ALT-803 Plus Nivolumab in Patients With Pretreated, Advanced or Metastatic Non-Small Cell Lung Cancer

Rucaparib and Pembrolizumab for Maintenance Therapy in Stage IV Non-Squamous Non-Small Cell Lung Cancer

Intratumoral Cisplatin for Resectable NSCLC

Atezolizumab and Varlilumab in Combination With Radiation Therapy for NSCLC

PRIMING

UCDCC#272: IL-2, Radiotherapy, and Pembrolizumab in Patients Refractory to Checkpoint Blockade

Phase I/II Study of Nivolumab and Ipilimumab Combined With Nintedanib in Non Small Cell Lung Cancer

Tiragolumab and Atezolizumab in Patients With Non-squamous Non-small Cell Lung Cancer (NSCLC) and Untreated Brain Metastases

Pembrolizumab + Imprime PGG for Metastatic Non-small Cell Lung Cancer After Progression on First-Line Therapy: Big Ten Cancer Research Consortium BTCRC-LUN15-017

Unresectable Stage IIIA/IIIB Non-small Cell Lung Cancer (NSCLC)

Biomarkers of Response to Ipilimumab and Nivolumab in First-line NSCLC

Pembro and Vorinostat for Patients With Stage IV Non-small Cell Lung Cancer (NSCLC)

A Trial of Integrating SBRT With Targeted Therapy in Stage IV Oncogene-driven NSCLC

Pembrolizumab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-IIIB Non-Small Cell Lung Cancer

Tarlox and Sotorasib in Patients With KRAS G12C Mutations

TELMA

NA_00092076

Platinum Doublet Chemotherapy and Proton Beam Radiation Therapy in Treating Patients With Stage II-III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

TG4010 and Nivolumab in Patients With Lung Cancer

Radical RADiotherapy and Immunotherapy for Metastatic CAncer of the Lung (RRADICAL)

Anti-PD-L1 in Stage IIIA(N2) Non-small Cell Lung Cancer (NSCLC)

Recombinant EphB4-HSA Fusion Protein and Pembrolizumab, MK-3475

Erlotinib With or Without Hydroxychloroquine in Chemo-Naive Advanced NSCLC and (EGFR) Mutations

Neoadjuvant Immunoradiation for Resectable Non-Small Cell Lung Cancer

TOP1705

Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer

SPACEWALK

Calypso-based Deep Inspiration Breath Hold (DIBH) Radiation Treatments of Lung Cancer

SABRseq

Atezolizumab and Tiragolumab in Patients With NSCLC or Advanced Solid Tumors Having Had Prior Treatment With a PD-1 Inhibitor

Dexamethasone Effects in Patients With Refractory Non-Small Cell Lung Cancer Using FLT Positron Emission Tomography

MEK162

Pembrolizumab Plus Bevacizumab for Treatment of Brain Metastases in Metastatic Melanoma or Non-small Cell Lung Cancer (NSCLC)

Prognostic Value of Sarcopenia and Nutritional Status in Early-stage Non-small Cell Lung Cancer

IRRADIATE-Lung

Ramucirumab and Pembrolizumab for the Treatment of EGFR Mutant Recurrent or Metastatic Non-small Cell Lung Cancer

Vinorelbine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Treatment and Liver Dysfunction

[18F]F-AraG/Total Body PET Imaging and Healthy Subjects and Lung Cancer Patients

Nintedanib in Molecularly Selected Patients With Advanced Non-Small Cell Lung Cancer

SWIPE

Postoperative Telerehabilitation in Older Adults